| To provide and promote evidence and recommendations for policy makers on methods to increase availability and decrease the consumer price of quality assured artemisinin-based combination therapies through the private sector.
PSI and its partners will achieve this goal through three primary objectives, which are to
provide policy makers with evidence and actionable recommendations in the following
areas:
-
Levels and trends in the availability, price, quality, volume, retailer perceptions,
and knowledge of antimalarial drugs at different service delivery points;
-
Wholesaler and retailer volumes and the components of the consumer price of
antimalarials, as well as current policy influences on the market, and specifically,
on mark-ups from import to outlet; and
-
Consumer treatment-seeking behavior, and volumes of specific antimalarials
consumed, to support the development and monitoring of policies and other
interventions to increase rates of effective malaria treatment.
A crosscutting objective will be to prepare and execute country-specific advocacy plans
and international dissemination activities to ensure that the evidence is effectively
translated into policy. |
